TR200103169T2 - 1,5-Benzodiazepin türevleri - Google Patents

1,5-Benzodiazepin türevleri

Info

Publication number
TR200103169T2
TR200103169T2 TR2001/03169T TR200103169T TR200103169T2 TR 200103169 T2 TR200103169 T2 TR 200103169T2 TR 2001/03169 T TR2001/03169 T TR 2001/03169T TR 200103169 T TR200103169 T TR 200103169T TR 200103169 T2 TR200103169 T2 TR 200103169T2
Authority
TR
Turkey
Prior art keywords
benzodiazepine derivatives
compound
cck
diarrhea
enantiomer
Prior art date
Application number
TR2001/03169T
Other languages
English (en)
Inventor
Colclough David
Hodgson Anne
Ryszard Szewczyk Jerzy
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9910366.5A external-priority patent/GB9910366D0/en
Priority claimed from GBGB0008179.4A external-priority patent/GB0008179D0/en
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of TR200103169T2 publication Critical patent/TR200103169T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Enantiomer açisindan zengi bir formül (I) bilesigi, hazirlanmasi, bilesigi içeren farmasötik bilesimler ve bunlarin sismanlik gibi CCK-A kaynakli hastalik veya rahatsizliklarin tedavisi için kullanimi tarif edilmektedir.
TR2001/03169T 1999-05-06 2000-05-04 1,5-Benzodiazepin türevleri TR200103169T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9910366.5A GB9910366D0 (en) 1999-05-06 1999-05-06 1,5-Benzodiazepine Derivatives
GBGB0008179.4A GB0008179D0 (en) 2000-04-05 2000-04-05 Chemical process

Publications (1)

Publication Number Publication Date
TR200103169T2 true TR200103169T2 (tr) 2002-04-22

Family

ID=26244033

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/03169T TR200103169T2 (tr) 1999-05-06 2000-05-04 1,5-Benzodiazepin türevleri

Country Status (21)

Country Link
EP (1) EP1212305A2 (tr)
JP (1) JP2002544200A (tr)
KR (1) KR20020012567A (tr)
CN (1) CN1161345C (tr)
AR (1) AR022044A1 (tr)
AU (1) AU4754800A (tr)
BR (1) BR0010338A (tr)
CA (1) CA2370801A1 (tr)
CO (1) CO5170461A1 (tr)
CZ (1) CZ20013988A3 (tr)
HK (1) HK1046138A1 (tr)
HU (1) HUP0201181A3 (tr)
IL (1) IL146124A0 (tr)
MX (1) MXPA01011267A (tr)
MY (1) MY138319A (tr)
NO (1) NO20015397L (tr)
NZ (1) NZ515048A (tr)
PE (1) PE20010110A1 (tr)
PL (1) PL351546A1 (tr)
TR (1) TR200103169T2 (tr)
WO (1) WO2000068209A2 (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005035793A2 (en) * 2003-10-09 2005-04-21 Decode Genetics Ehf. Cckar markers and haplotypes associated with extreme weight conditions
EP1753766A1 (en) 2004-05-25 2007-02-21 Pfizer Products Inc. Tetraazabenzo(e)azulene derivatives and analogs thereof
AU2020363377A1 (en) 2019-10-07 2022-04-21 Kallyope, Inc. GPR119 agonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9307833D0 (en) * 1993-04-15 1993-06-02 Glaxo Inc Modulators of cholecystokinin and gastrin

Also Published As

Publication number Publication date
AR022044A1 (es) 2002-09-04
MY138319A (en) 2009-05-29
IL146124A0 (en) 2002-07-25
CN1161345C (zh) 2004-08-11
WO2000068209A3 (en) 2001-03-01
EP1212305A2 (en) 2002-06-12
NZ515048A (en) 2004-01-30
NO20015397D0 (no) 2001-11-05
CA2370801A1 (en) 2000-11-16
PE20010110A1 (es) 2001-03-05
MXPA01011267A (es) 2002-05-06
NO20015397L (no) 2001-11-05
PL351546A1 (en) 2003-05-05
HK1046138A1 (zh) 2002-12-27
KR20020012567A (ko) 2002-02-16
HUP0201181A2 (hu) 2002-12-28
WO2000068209A2 (en) 2000-11-16
HUP0201181A3 (en) 2003-10-28
CO5170461A1 (es) 2002-06-27
JP2002544200A (ja) 2002-12-24
CN1362949A (zh) 2002-08-07
AU4754800A (en) 2000-11-21
BR0010338A (pt) 2002-02-13
CZ20013988A3 (cs) 2002-02-13

Similar Documents

Publication Publication Date Title
HK1040721A1 (en) Glycopeptide derivatives and pharmaceutical compositions containing the same
TR200101961T2 (tr) 1,2-halkalı kinolin türevleri
YU21401A (sh) Tetrahidropiridoetri
TR200101499T1 (tr) Azepinoindol türevleri, hazırlanmaları ve kullanımları.
BG103485A (en) Ketobanzamides as calpain inhibitors
SE0102315D0 (sv) Compounds
TR200001012T2 (tr) Yeni ariloksi-alkil-dialkilaminler.
TR200101567T2 (tr) Yeni triazolo(4.5-D)pirimidin bileşimleri.
DE60112330D1 (en) Pyrazolopyridinderivate
IL151201A0 (en) Alkylated imidazopyridine derivatives and pharmaceutical compositions containing the same
IL140070A0 (en) Benzamide derivatives and pharmaceutical compositions containing the same
EE9900450A (et) Tetrahüdropüridoühendid, neid sisaldav ravim ja nende kasutamine
SE9802937D0 (sv) Novel compounds
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
ATE251162T1 (de) Triazolo(4,5-d)pyrimidin-verbindungen
DE60201074D1 (en) Pyrazolopyridinderivate
SE9904128D0 (sv) Novel compounds
TR200103169T2 (tr) 1,5-Benzodiazepin türevleri
NO20020914D0 (no) Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav
MY133140A (en) N-substituted azabicycloheptane derivatives, their preparation and use
TWI231815B (en) Glycopeptide derivatives and pharmaceutical compositions containing the same for use as antibacterial agents
PE61999A1 (es) Compuestos de tetrahidropiridina
ATE239015T1 (de) N-substituierte azabicycloheptan-derivate, ihre herstellung und verwendung